Search clinical trials for: Lina LibrataTM

Total 664 results

Lawson Health Research Institute
Orthopaedic Trauma Association

Completed

Open Reduction Syndesmosis Tightrope Versus Screw Fixation

Ankle Fractures

Canada
Lina Xu

Completed

A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis

Osteoarthritis of the Knee

United States
Charles University, Czech Republic

Completed

Safety Evaluation of Adverse Reactions in Diabetes (SAFEGUARD)

Type 2 Diabetes Mellitus

Czechia
Centro Universitario de Ciencias de la Salud, Mexico

Completed

Conjugated Linoleic Acid / Leucine Versus Metformin on Visceral Fat in Metabolic Syndrome

Metabolic Syndrome
Changi General Hospital

Unknown

Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults (CGH-LiNASH)

Weight Loss | Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)

Singapore
Boryung Pharmaceutical Co., Ltd

Completed

A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers

Hypertension

Korea, Republic of
American University of Beirut Medical Center
Azusa Pacific University; Daisy Foundation

Unknown

Honey or Olive Oil for Treating Oral Mucositis in Children and Adults With Leukemia Receiving Intensive Chemotherapy

Leukemia | Oral Mucositis

Lebanon
Cancer Care Ontario
University of Toronto; Roswell Park Cancer Institute; Mount Sinai Services; Canadian... and other collaborators

Completed

Flaxseed Intervention Study to Assess Sex Hormone Levels Among Post-Menopausal Women

Healthy

Canada
University of Erlangen-Nürnberg Medical School

Completed

Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes.

Type 2-diabetes

Germany
University of Saskatchewan

Completed

Flaxseed Lignan Supplementation in Elderly Participants With Stage I Hypertension

Hypertension

Canada
Boehringer Ingelheim

Completed

BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
National Nutrition and Food Technology Institute

Unknown

The Effects of Hesperidin and Flaxseed on Biochemical Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease

Non Alcoholic Steatohepatitis

Iran, Islamic Republic of
Hospital Universitari de Bellvitge
Institut d'Investigació Biomèdica de Bellvitge

Unknown

E6/E7 mRNA Performance to Detect HSIL and Cost-effectiveness Analysis of This Screening Strategy in HIV + MSM (ELAVI-67)

Hiv | Anal Cancer | HPV - Anogenital Human Papilloma Virus Infection | HSIL, High Grade Squamous Intraepithelial Lesions

Spain
Seoul National University Hospital
Daewoong Pharmaceutical Co. LTD.

Completed

The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones

Diabetes Mellitus, Type 2

Korea, Republic of
Boehringer Ingelheim
Eli Lilly and Company

Completed

Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Linagliptin Compared With the Free Combination of Empagliflozin Tablet and Linagliptin Tablet in Healthy Male and Female Subjects

Healthy

Germany
Yanbing Li

Unknown

A Study of Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With Type 2 Diabetes(PDPD) With Premixed Insulin Therapy

Type 2 Diabetes Mellitus | Peritoneal Dialysis

China
Seagen Inc.

Completed

A Safety Study of SGN-CD19A for B-Cell Lymphoma

Lymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Burkitt Lymphoma | Lymphoma, Mantle-Cell | Precursor B-cell Lymphoblastic Leukemia-Lymphoma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Texas A&M University

Completed

FlaxFx, A Research Study of the Effects of Flaxseed Lignans on Colon Health (FlaxFx)

Healthy

United States
Rabin Medical Center

Unknown

Safety and Efficiency of Linagliptin (Trajenta) in the Setting of Internal Medicine Department

DM2
The Second Affiliated Hospital of Chongqing Medical...
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China

Unknown

Human Amniotic Epithelial Cells for Asherman's Syndrome

Asherman's Syndrome
Evidem Consultores SL
Boehringer Ingelheim; Merck Serono International SA; European Commission

Unknown

Prevention of Microvascular Complications in Prediabetes e-PREDICE Study (ePREDICE)

PreDiabetes

Spain
National Institutes of Health Clinical Center (CC)

Completed

Drug Interaction Study Between Inhaled Beclomethasone and Protease Inhibitors in Healthy Volunteers

Asthma | HIV

United States
Seagen Inc.

Completed

A Safety Study of SGN-CD19A for Leukemia and Lymphoma

Burkitt Lymphoma | Precursor B-cell Lymphoblastic Leukemia-Lymphoma

United States
Ironwood Pharmaceuticals, Inc.
Forest Laboratories

Completed

Trial of Linaclotide in Patients With Chronic Idiopathic Constipation

Chronic Idiopathic Constipation

United States
University of Aarhus

Unknown

Prevalence and Significance of Mutations in Genes Encoding NaPi-co-transporters in the Development of CAVD

Aortic Stenosis | Aortic Valve Calcification

Denmark
St. Jude Children's Research Hospital
National Cancer Institute (NCI); Assisi Foundation

Completed

Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia

Lymphoblastic Leukemia, Acute

United States
Katarina Kos
Diabetes UK

Completed

The Microvascular Function of GLP-1 and Its Analogues

Obesity | Type 2 Diabetes

United Kingdom
RWTH Aachen University

Terminated

Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus (Lina-Plaque)

Diabetes Mellitus Type 2 (T2DM) | Vascular Inflammation | Plaque Morphology

Germany, Netherlands
RWTH Aachen University

Terminated

Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus (Diast Dysfkt)

Diabetes Mellitus Type 2 (T2DM) | Left Ventricular Diastolic Dysfunction

Germany
Boehringer Ingelheim
Eli Lilly and Company

Completed

MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin

Diabetes Mellitus, Type 2

Germany, Spain, United States, Canada, Taiwan, Korea, Republic of, Finland, Denmark, France, Japan, Philippines, Vietnam
Profil Institut für Stoffwechselforschung GmbH

Completed

Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment

Diabetes Mellitus

Germany
GlaxoSmithKline

Completed

Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment

Prostatic Hyperplasia

United States, Netherlands, Spain, Taiwan, Bulgaria, Estonia, Hungary, Italy, Belgium, Thailand, Israel, Germany, Canada, Korea, Republic of, Norway, Finland, Russian Federation, Romania, Brazil, France, Slovakia, Philippines, South... and more
Boehringer Ingelheim
Eli Lilly and Company

Completed

Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy

Diabetes Mellitus, Type 2

United States
Air Force Military Medical University, China

Unknown

Biomarkers and Functional Imaging in Predicting Response of Esophageal Cancer

Esophageal Cancer

China
Adelphi Values LLC
Blueprint Medicines Corporation

Completed

Patient-Reported Outcome Questionnaire for Systemic Mastocytosis

Mast Cell Leukemia (MCL) | Aggressive Systemic Mastocytosis (ASM) | SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD) | Smoldering Systemic Mastocytosis (SSM) | Indolent Systemic Mastocytosis (ISM) ISM Subgroup Fully Recruited

United States
University of Kansas Medical Center
Mallinckrodt

Completed

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

Graft Versus Host Disease | Stem Cell Leukemia of Unclear Lineage

United States
University of Rochester
National Institutes of Health (NIH); Dartmouth-Hitchcock Medical Center

Completed

Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children

Influenza

United States
Dr. Grant Pierce

Completed

Effects of Dietary Flaxseed on Symptoms of Cardiovascular Disease in Patients With Peripheral Arterial Disease (FLAXPAD)

Peripheral Arterial Disease
Beth Israel Deaconess Medical Center

Completed

The Effect of Linagliptin on Mitochondrial and Endothelial Function

Type II Diabetes Mellitus

United States
Wingate Institute of Neurogastroenterology

Unknown

Caecal pH as a Biomarker for Irritable Bowel Syndrome

Irritable Bowel Syndrome

United Kingdom
South Eastern Sydney Local Health District
GlaxoSmithKline

Unknown

The International ITP Registry

Thrombocytopenia

Singapore, Korea, Republic of, Thailand, Turkey, Australia, Colombia, Kuwait, Malaysia, Taiwan, Uruguay
AstraZeneca
Ironwood Pharmaceuticals, Inc.

Completed

A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) (D5630C00001)

Irritable Bowel Syndrome With Constipation (IBS-C)

United States, Australia, China, New Zealand, Canada
Boehringer Ingelheim
Eli Lilly and Company

Completed

Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Canada, France, Guatemala, Italy, Korea, Republic of, Mexico, Poland, Russian Federation
Boehringer Ingelheim
Eli Lilly and Company

Completed

Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic Control

Diabetes Mellitus, Type 2

China, Malaysia, Philippines
Boehringer Ingelheim
Eli Lilly and Company

Completed

Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy

Diabetes Mellitus, Type 2

China, Malaysia, Philippines
Genuine Research Center, Egypt
Eva Pharma

Completed

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

Healthy

Egypt
Boehringer Ingelheim
Eli Lilly and Company

Completed

Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/1000mg) Extended Release in Healthy Subjects.

Healthy

Germany
Boehringer Ingelheim
Eli Lilly and Company

Completed

Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended Release in Healthy Subjects

Healthy

Germany
Boehringer Ingelheim
Eli Lilly and Company

Completed

Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended Release in Healthy Subjects

Healthy

Germany
University of Virginia

Completed

Single-dose Linaclotide for Capsule Endoscopy Preparation

Ulcerative Colitis | Gastrointestinal Bleeding | Crohn's

United States

Search clinical trials for: Lina LibrataTM

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations